Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We describe here the oncostatin M (OSM)-dependent inhibition of in vivo tumour formation after intracerebral inoculation of glioblastoma cells in mice. We generated human glioblastoma cells transfected with the OSM gene under the control of a tetracycline-response promoter. Upon removal of tetracycline from the medium, cells exhibited a differentiated cell morphology, while proliferation was significantly inhibited. After implantation of these cells into nude mice brains, large tumours developed in animals lacking OSM expression, whereas no tumour formation was observed in mice with induced OSM expression. Our results suggest that OSM exerts pronounced antitumorigenic effects on glioblastoma cells in vivo and provide arguments for a therapeutic application of OSM in humans.

Original publication

DOI

10.1046/j.1471-4159.2001.00202.x

Type

Journal article

Journal

Journal of neurochemistry

Publication Date

03/2001

Volume

76

Pages

1589 - 1592

Addresses

Department of Neurology, University of Münster, Münster, Germany.

Keywords

Tumor Cells, Cultured, Animals, Humans, Mice, Mice, Nude, Glioma, Brain Neoplasms, Tetracycline, Peptides, Recombinant Proteins, Antineoplastic Agents, Transplantation, Heterologous, Transfection, Cell Division, Female, Oncostatin M, Promoter Regions, Genetic